NLRP3 Inflammasome: Small Molecule Oral Signaling Inhibitor Icaritin Analog to Improve Hematopoiesis by Inhibiting NLRP3 Inflammasome Activation in MDS

FOR MORE INFORMATION ON THIS TECHNOLOGY, PLEASE CONTACT OUR OFFICE

Contact

Haskell Adler PhD MBA CLP
Senior Licensing Manager
Registered Patent Agent
Haskell.Adler@Moffitt.org
(813) 745-6596

16MA006N